1. Academic Validation
  2. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death

The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death

  • Mol Cell. 2005 Jun 10;18(6):637-50. doi: 10.1016/j.molcel.2005.05.010.
Shairaz Baksh 1 Stella Tommasi Sarah Fenton Victor C Yu L Miguel Martins Gerd P Pfeifer Farida Latif Julian Downward Benjamin G Neel
Affiliations

Affiliation

  • 1 Cancer Biology Program, Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, 1038 NRB, 330 Brookline Avenue, Boston, Massachusetts 02215, USA. [email protected]
Abstract

Tumor cells typically resist programmed cell death (Apoptosis) induced by death receptors. Activated death receptors evoke Bax conformational change, cytochrome c release, and cell death. We report that the tumor suppressor gene RASSF1A is required for death receptor-induced Bax conformational change and Apoptosis. TNFalpha or TRAIL stimulation induced recruitment of RASSF1A and MAP-1 to receptor complexes and promoted complex formation between RASSF1A and the BH3-like protein MAP-1. Normally, MAP-1 is inhibited by an intramolecular interaction. RASSF1A/MAP-1 binding relieved this inhibitory interaction, resulting in MAP-1 association with Bax. Deletion of the RASSF1A gene or short hairpin silencing of either RASSF1A or MAP-1 expression blocked MAP-1/Bax interaction, Bax conformational change and mitochondrial membrane insertion, cytochrome c release, and Apoptosis in response to death receptors. Our findings identify RASSF1A and MAP-1 as important components between death receptors and the apoptotic machinery and reveal a potential link between tumor suppression and death receptor signaling.

Figures